DexCom, Inc.
corporate_fare Company Profile
DexCom, Inc. (NASDAQ:DXCM) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 21 items for DXCM at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-29, rated 7/10. Across its 20 most recent items scored 7 or higher, the top rating is 9/10, with 10 rated 8 or above. Recent SEC coverage for DXCM spans 10-Q, 8-K, 10-K.
Recent high-impact activity:
- DexCom 10-Q: Q3 Revenue $1.34B, Operating Income Up 35%, $1.0B Buyback Completed
- Dexcom Beats on Q3, Raises 2026 Guidance and Authorizes $1.0 Billion Buyback
- DexCom Posts $275.1M Third-Quarter Net Income
- NEJM Publication of CONNECT Trial Boosts DexCom's Medicare Coverage Hopes
- Dexcom Q2 Revenue Jumps 13% to $1.31B, Operating Income Surges 50%
Financial Snapshot
Short Interest & Short Volume
2.81 days to coverFINRA reported short interest of 15,933,006 shares in DXCM as of the October 30, 2026 settlement, a 1.6% increase from the prior period — about 2.8 days to cover at its recent average daily volume. On November 20, 2026, 58.3% of DXCM volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.